The role of B cells and autoantibodies in rheumatoid arthritis

Pathophysiology

Volumn 12, Issue 3, 2005, Pages 203-216

  Chaiamnuay, Sumapa ^a   Bridges Jr , S Louis ^a  

^a The University of Alabama at Birmingham   (United States)

Author keywords

Anti CCP antibodies; Autoantibodies; B lymphocytes; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

AUTOANTIBODY; CD20 ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLYCOLYTIC ENZYME; METHOTREXATE; RHEUMATOID FACTOR; RITUXIMAB; TOLL LIKE RECEPTOR;

ANGIOGENESIS; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL FUNCTION; CELL INFILTRATION; CELL MATURATION; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE MODEL; DRUG DESIGN; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATION; LEUKOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; SYNOVITIS; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

EID: 25444506158     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2005.07.007     Document Type: Article

References (164)

1. G.S. Firestein Evolving concepts of rheumatoid arthritis Nature 423 6937 2003 356 361
2. S. De Vita, F. Zaja, S. Sacco, A. De Candia, R. Fanin, and G. Ferraccioli Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells Arthritis Rheum. 46 8 2002 2029 2033
3. J.C. Edwards, L. Szczepanski, J. Szechinski, A. Filipowicz-Sosnowska, P. Emery, and D.R. Close Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis N. Engl. J. Med. 350 25 2004 2572 2581
4. C.A.J. Janeway, P. Travers, M. Walport, M.J. Shlomchik (Eds.), The development and survival of lymphocytes, Immunobiology, Garland Publishing, New York, 2001, pp. 221-293.
5. E. Weinstein, E. Peeva, C. Putterman, and B. Diamond B-cell biology Rheum. Dis. Clin. N. Am. 30 1 2004 159 174
6. M. Muramatsu, K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme Cell 102 5 2000 553 563
7. P. Revy, T. Muto, Y. Levy, F. Geissmann, A. Plebani, O. Sanal, N. Catalan, M. Forveille, R. Dufourcq-Labelouse, A. Gennery, I. Tezcan, F. Ersoy, H. Kayserili, A.G. Ugazio, N. Brousse, M. Muramatsu, L.D. Notarangelo, K. Kinoshita, T. Honjo, A. Fischer, and A. Durandy Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2) Cell 102 5 2000 565 575
8. L. Guzman-Rojas, J.C. Sims-Mourtada, R. Rangel, and H. Martinez-Valdez Life and death within germinal centres: a double-edged sword Immunology 107 2 2002 167 175
9. Z. Zhang, M. Zemlin, Y.H. Wang, D. Munfus, L.E. Huye, and H.W. Findley Contribution of Vh gene replacement to the primary B cell repertoire Immunity 19 1 2003 21 31
10. Z. Zhang, X. Wu, B.H. Limbaugh, and S.L. Bridges Jr. Expression of recombination-activating genes and terminal deoxynucleotidyl transferase and secondary rearrangement of immunoglobulin kappa light chains in rheumatoid arthritis synovial tissue Arthritis Rheum. 44 10 2001 2275 2284
11. H. Wardemann, S. Yurasov, A. Schaefer, J.W. Young, E. Meffre, and M.C. Nussenzweig Predominant autoantibody production by early human B cell precursors Science 301 5638 2003 1374 1377
12. D.A. Nemazee, and K. Burki Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes Nature 337 6207 1989 562 566
13. S.L. Tiegs, D.M. Russell, and D. Nemazee Receptor editing in self-reactive bone marrow B cells J. Exp. Med. 177 4 1993 1009 1020
14. D. Gay, T. Saunders, S. Camper, and M. Weigert Receptor editing: an approach by autoreactive B cells to escape tolerance J. Exp. Med. 177 4 1993 999 1008
15. M. Zemlin, R.L. Schelonka, K. Bauer, and H.W. Schroeder Jr. Regulation and chance in the ontogeny of B and T cell antigen receptor repertoires Immunol. Res. 26 13 2002 265 278
16. A. Rahman, I. Giles, J. Haley, and D. Isenberg Systematic analysis of sequences of anti-DNA antibodies - relevance to theories of origin and pathogenicity Lupus 11 12 2002 807 823
17. N.J. Zvaifler Rheumatoid synovitis. An extravascular immune complex disease Arthritis Rheum. 17 3 1974 297 305
18. H.E. Jasin Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis Arthritis Rheum. 28 1985 241 248
19. J.T. Halla, J.E. Volanakis, J.G. Hardin, and R.E. Schrohenloher Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity Clin. Exp. Immunol. 34 2 1978 226 234
20. N.J. Zvaifler Immunopathology of joint inflammation in rheumatoid arthritis Adv. Immunol. 16 1973 265 336
21. V. Kouskoff, A.S. Korganow, V. Duchatelle, C. Degott, C. Benoist, and D. Mathis Organ-specific disease provoked by systemic autoimmunity Cell 87 5 1996 811 822
22. Basic concepts in immunology C.A.J. Janeway P. Travers M. Walport M.J. Shlomchik Immunobiology 2001 Garland Publishing New York 1 34
23. I. Matsumoto, A. Staub, C. Benoist, and D. Mathis Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme Science 286 5445 1999 1732 1735
24. H.J. Ditzel The K/BxN mouse: a model of human inflammatory arthritis Trends Mol. Med. 10 1 2004 40 45
25. T. Dorner, and G.R. Burmester The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets Curr. Opin. Rheumatol. 15 3 2003 246 252
26. H. Ji, K. Ohmura, U. Mahmood, D.M. Lee, F.M. Hofhuis, and S.A. Boackle Arthritis critically dependent on innate immune system players Immunity 16 2 2002 157 168
27. S.L. Bridges Jr. Update on autoantibodies in rheumatoid arthritis Curr. Rheumatol. Rep. 6 5 2004 343 350
28. E.A. Leadbetter, I.R. Rifkin, A.M. Hohlbaum, B.C. Beaudette, M.J. Shlomchik, and A. Marshak-Rothstein Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors Nature 416 6881 2002 603 607
29. W.P. Arend The innate immune system in rheumatoid arthritis Arthritis Rheum. 44 10 2001 2224 2234
30. M.J. Shlomchik, J.E. Craft, and M.J. Mamula From T to B and back again: positive feedback in systemic autoimmune disease Nat. Rev. Immunol. 1 2 2001 147 153
31. D.A. Carson, P.P. Chen, and T.J. Kipps New roles for rheumatoid factor J. Clin. Invest. 87 1991 379 383
32. A. Lanzavecchia Antigen-specific interaction between T and B cells Nature 314 6011 1985 537 539
33. D.H. Raulet MHC class I-deficient mice Adv. Immunol. 55 1994 381 421
34. O.T. Chan, L.G. Hannum, A.M. Haberman, M.P. Madaio, and M.J. Shlomchik A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus J. Exp. Med. 189 10 1999 1639 1648
35. M. Ziff Relation of cellular infiltration of rheumatoid synovial membrane to its immune response Arthritis Rheum. 17 1974 313 319
36. T. Iguchi, and M. Ziff Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation J. Clin. Invest. 77 2 1986 355 361
37. A.C. van Dinther-Janssen, S.T. Pals, R. Scheper, F. Breedveld, and C.J. Meijer Dendritic cells and high endothelial venules in the rheumatoid synovial membrane J. Rheumatol. 17 1 1990 11 17
38. I. Randen, O.J. Mellbye, Ø. Førre, and J.B. Natvig The identification of germinal centres and follicular dendritic networks in rheumatoid synovial tissue Scand. J. Immunol. 41 1995 481 486
39. A.C. Steere, P.H. Duray, and E.C. Butcher Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Comparison with rheumatoid synovium and tonsillar lymphoid tissue Arthritis Rheum. 31 4 1988 487 495
40. A.E. Schröder, J. Sieper, and C. Berek Antigen-dependent B cell differentiation in the synovial tissue of a patient with reactive arthritis Mol. Med. 3 4 1997 260 272
41. I. Kumon In situ characterization of mononuclear cell phenotype in intrahepatic lymphoid follicles in patients with chronic viral hepatitis Gastroenterol. Japonica 27 5 1992 638 645
42. M.A. Freni, D. Artuso, G. Gerken, C. Spanti, T. Marafioti, and N. Alessi Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohistochemical characterization, and relation to markers of autoimmunity Hepatology 22 2 1995 389 394
43. J.F. Mosnier, C. Degott, P. Marcellin, D. Henin, S. Erlinger, and J.P. Benhamou The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study Hepatology 17 3 1993 366 371
44. M.P. Armengol, M. Juan, A. Lucas-Martin, M.T. Fernandez-Figueras, D. Jaraquemada, and T. Gallart Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers Am. J. Pathol. 159 3 2001 861 873
45. S.K. Lee, S.L. Bridges Jr., P.M. Kirkham, W.J. Koopman, and H.W. Schroeder Jr. Evidence of antigen receptor-influenced oligoclonal B lymphocyte expansion in the synovium of a patient with longstanding rheumatoid arthritis J. Clin. Invest. 93 1994 361 370
46. S.L. Bridges Jr., B.E. Clausen, J.C. Lavelle, P.G. Fowler, W.J. Koopman, and H.W. Schroeder Jr. Analysis of immunoglobulin gamma heavy chains from rheumatoid arthritis synovium: evidence of antigen-driven selection Ann. N.Y. Acad. Sci. 764 1995 450 452
47. B.E. Clausen, S.L. Bridges Jr., J.C. Lavelle, P.G. Fowler, S. Gay, and W.J. Koopman Clonally-related immunoglobulin VH domains and non-random use of DH gene segments in rheumatoid arthritis synovium Mol. Med. 4 1998 240 257
48. A.E. Schröder, A. Greiner, C. Seyfert, and C. Berek Differentiation of B cells in the non-lymphoid tissue of the synovial membrane of patients with rheumatoid arthritis Proc. Natl. Acad. Sci. U.S.A. 93 1996 221 225
49. K. Itoh, E. Meffre, E. Albesiano, A. Farber, D. Dines, and P. Stein Immunoglobulin heavy chain variable region gene replacement as a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytes J. Exp. Med. 192 8 2000 1151 1164
50. Z. Zhang, and S.L. Bridges Jr. Expression of RAG and TdT and evidence of receptor revision in synovial B lymphocytes in rheumatoid arthritis Scand. J. Immunol. 50 1 1999 101 (abstract)
51. S.L. Bridges Jr., S.K. Lee, M.L. Johnson, J.C. Lavelle, P.G. Fowler, and W.J. Koopman Somatic mutation and CDR3 lengths of immunoglobulin k light chains expressed in patients with rheumatoid arthritis and normal individuals J. Clin. Invest. 96 1995 831 841
52. S.L. Bridges Jr. Frequent N addition and clonal relatedness among immunoglobulin lambda light chains expressed in rheumatoid arthritis synovia and PBL, and the influence of Vlambda gene segment utilization on CDR3 length Mol. Med. 4 8 1998 525 553
53. U.G. Wagner, P.J. Kurtin, A. Wahner, M. Brackertz, D.J. Berry, and J.J. Goronzy The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis J. Immunol. 161 11 1998 6390 6397
54. T. Manser Textbook germinal centers? J. Immunol. 172 6 2004 3369 3375
55. C.M. Weyand, P.J. Kurtin, and J.J. Goronzy Ectopic lymphoid organogenesis: a fast track for autoimmunity Am. J. Pathol. 159 3 2001 787 793
56. C.C. Reparon-Schuijt, W.J. Van Esch, C. Van Kooten, E.W. Levarht, and F.C. Breedveld Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients Arthritis Rheum. 41 12 1998 2211 2220
57. J.H. Ruth, J.B. Rottman, K.J. Katschke Jr., S. Qin, L. Wu, and G. LaRosa Selective lymphocyte chemokine receptor expression in the rheumatoid joint Arthritis Rheum. 44 12 2001 2750 2760
58. C.M. Weyand, and J.J. Goronzy Ectopic germinal center formation in rheumatoid synovitis Ann. N.Y. Acad. Sci. 987 2003 140 149
59. K.M. Ansel, R.B. Harris, and J.G. Cyster CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity Immunity 16 1 2002 67 76
60. M.B. Alimzhanov, D.V. Kuprash, M.H. Kosco-Vilbois, A. Luz, R.L. Turetskaya, and A. Tarakhovsky Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice Proc. Natl. Acad. Sci. U.S.A. 94 17 1997 9302 9307
61. G.J. Silverman, and D.A. Carson Roles of B cells in rheumatoid arthritis Arthritis Res. Ther. 5 Suppl. 4 2003 S1 S6
62. M.E. Duddy, A. Alter, and A. Bar-Or Distinct profiles of human B cell effector cytokines: a role in immune regulation? J. Immunol. 172 6 2004 3422 3427
63. S. Takemura, P.A. Klimiuk, A. Braun, J.J. Goronzy, and C.M. Weyand T cell activation in rheumatoid synovium is B cell dependent J. Immunol. 167 8 2001 4710 4718
64. A. Ruddell, P. Mezquita, K.A. Brandvold, A. Farr, and B.M. Iritani B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis Am. J. Pathol. 163 6 2003 2233 2245
65. T. Pap, M. Nawrath, J. Heinrich, M. Bosse, A. Baier, and K.M. Hummel Cooperation of Ras- and c-Myc-dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis Arthritis Rheum. 50 9 2004 2794 2802
66. L.R. Lard, H. Visser, I. Speyer, I.E. vander Horst-Bruinsma, A.H. Zwinderman, and F.C. Breedveld Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies Am. J. Med. 111 6 2001 446 451
67. L.W. Moreland, and S.L. Bridges Jr. Early rheumatoid arthritis: a medical emergency? Am. J. Med. 111 6 2001 498 500
68. M.A. van Boekel, E.R. Vossenaar, F.H. van den Hoogen, and W.J. van Venrooij Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value Arthritis Res. 4 2 2002 87 93
69. E. Waaler On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles Acta Pathol. Microbiol. Scand. 17 1940 172 188
70. R.H. Shmerling, and T.L. Delbanco The rheumatoid factor: an analysis of clinical utility Am. J. Med. 91 5 1991 528 534
71. W. Swedler, J. Wallman, C.J. Froelich, and M. Teodorescu Routine measurement of IgM, IgG, and IgA rheumatoid factors: high sensitivity, specificity, and predictive value for rheumatoid arthritis J. Rheumatol. 4 6 1997 1037 1044
72. A. Davidson, and S.L. Bridges Jr. Autoimmunity in rheumatoid arthritis B.F. Haynes D.S. Pisetsky E.W. St Clair RA: A Textbook of Rheumatoid Arthritis 2003 Lippincott Williams & Wilkins 197 212
73. A.J. MacGregor, H. Snieder, A.S. Rigby, M. Koskenvuo, J. Kaprio, and K. Aho Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins Arthritis Rheum. 43 1 2000 30 37
74. D. Jawaheer, W. Thomson, A.J. MacGregor, D. Carthy, J. Davidson, and P.A. Dyer Homozygosity" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins Arthritis Rheum. 37 5 1994 681 686
75. G.S. Alarcón, W.J. Koopman, R.T. Acton, and B.O. Barger Seronegative rheumatoid arthritis. A distinct immunogenetic disease? Arthritis Rheum. 25 5 1982 502 507
76. P. Garred, H.O. Madsen, J. Petersen, H. Marquart, T.M. Hansen, and Freiesleben CC chemokine receptor 5 polymorphism in rheumatoid arthritis J. Rheumatol. 25 8 1998 1462 1465
77. L.R. Lard, F.A. van Gaalen, J.J. Schonkeren, E.J. Pieterman, G. Stoeken, and K. Vos Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis Arthritis Rheum. 48 7 2003 1841 1848
78. M. Heliovaara, K. Aho, P. Knekt, O. Impivaara, A. Reunanen, and A. Aromaa Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis Ann. Rheum. Dis. 59 8 2000 631 635
79. K.G. Saag, J.R. Cerhan, S. Kolluri, K. Ohashi, G.W. Hunninghake, and D.A. Schwartz Cigarette smoking and rheumatoid arthritis severity Ann. Rheum. Dis. 56 8 1997 463 469
80. T. Jonsson, J. Thorsteinsson, and H. Valdimarsson Does smoking stimulate rheumatoid factor production in non-rheumatic individuals? APMIS 106 10 1998 970 974
81. S.L. Bridges Jr., and A.E. Davidson Rheumatoid factor W.J. Koopman L.W. Moreland Arthritis and Allied Conditions 2005 Lippincott, Williams & Wilkins Philadelphia 1227 1247
82. S. Rantapää-Dahlqvist, B.A. de Jong, E. Berglin, G. Hallmans, G. Wadell, and H. Stenlund Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis Arthritis Rheum. 48 10 2003 2741 2749
83. T. Jonsson, K. Steinsson, H. Jonsson, A.J. Geirsson, J. Thorsteinsson, and H. Valdimarsson Combined elevation of IgM and IgA rheumatoid factor has high diagnostic specificity for rheumatoid arthritis Rheumatol. Int. 18 3 1998 119 122
84. R.L. Nienhuis, and E. Mandema A new serum factor in patients with rheumatoid arthritis: the antiperinuclear factor Ann. Rheum. Dis. 23 1964 302 305
85. B.J. Young, R.K. Mallya, R.D. Leslie, C.J. Clark, and T.J. Hamblin Anti-keratin antibodies in rheumatoid arthritis Br. Med. J. 2 6182 1979 97 99
86. M. Sebbag, M. Simon, C. Vincent, C. Masson-Bessiere, E. Girbal, and J.J. Durieux The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies J. Clin. Invest. 95 6 1995 2672 2679
87. R.M. Hoet, A.M. Boerbooms, M. Arends, D.J. Ruiter, and W.J. van Venrooij Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin Ann. Rheum. Dis. 50 9 1991 611 618
88. G.A. Schellekens, B.A. de Jong, F.H. van den Hoogen, L.B. van de Putte, and W.J. van Venrooij Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies J. Clin. Invest. 101 1 1998 273 281
89. E. Girbal-Neuhauser, J.J. Durieux, M. Arnaud, P. Dalbon, M. Sebbag, and C. Vincent The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are post-translationally generated on various sites of (pro)filaggrin by deimination of arginine residues J. Immunol. 162 1 1999 585 594
90. E.R. Vossenaar, N. Despres, E. Lapointe, H.A. van der, M. Lora, and T. Senshu Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin Arthritis Res. Ther. 6 2 2004 R142 R150
91. G.A. Schellekens, H. Visser, B.A. de Jong, F.H. van den Hoogen, J.M. Hazes, and F.C. Breedveld The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide Arthritis Rheum. 43 1 2000 155 163
92. C.C. Reparon-Schuijt, W.J. Van Esch, C. Van Kooten, G.A. Schellekens, B.A. de Jong, and W.J. van Venrooij Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis Arthritis Rheum. 44 1 2001 41 47
93. D. Baeten, I. Peene, A. Union, L. Meheus, M. Sebbag, and G. Serre Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies Arthritis Rheum. 44 10 2001 2255 2262
94. E.R. Vossenaar, T.J. Smeets, M.C. Kraan, J.M. Raats, W.J. van Venrooij, and P.P. Tak The presence of citrullinated proteins is not specific for rheumatoid synovial tissue Arthritis Rheum. 50 11 2004 3485 3494
95. E.R. Vossenaar, and W.J. van Venrooij Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis Arthritis Res. Ther. 6 3 2004 107 111
96. X. Chang, R. Yamada, A. Suzuki, T. Sawada, S. Yoshino, and S. Tokuhiro Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis Rheumatology (Oxford) 44 1 2005 40 50
97. E.R. Vossenaar, T.R. Radstake, H.A. van der, M.A. van Mansum, C. Dieteren, and D.J. de Rooij Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages Ann. Rheum. Dis. 63 4 2004 373 381
98. H. Asaga, and A. Ishigami Protein deimination in the rat brain after kainate administration: citrulline-containing proteins as a novel marker of neurodegeneration Neurosci. Lett. 299 12 2001 5 8
99. H. Asaga, M. Yamada, and T. Senshu Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages Biochem. Biophys. Res. Commun. 243 3 1998 641 646
100. A. Suzuki, R. Yamada, X. Chang, S. Tokuhiro, T. Sawada, and M. Suzuki Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis Nat. Genet. 34 4 2003 395 402
101. A. Barton, J. Bowes, S. Eyre, K. Spreckley, A. Hinks, and S. John A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population Arthritis Rheum. 50 4 2004 1117 1121
102. I. Vallbracht, J. Rieber, M. Oppermann, F. Forger, U. Siebert, and K. Helmke Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis Ann. Rheum. Dis. 63 9 2004 1079 1084
103. D.M. Lee, and P.H. Schur Clinical utility of the anti-CCP assay in patients with rheumatic diseases Ann. Rheum. Dis. 62 9 2003 870 874
104. J.M. Pawlotsky, M. Ben Yahia, C. Andre, M.C. Voisin, L. Intrator, and F. Roudot-Thoraval Immunological disorders in C virus chronic active hepatitis: a prospective case-control study Hepatology 19 4 1994 841 848
105. M. Bombardieri, C. Alessandri, G. Labbadia, C. Iannuccelli, F. Carlucci, and V. Riccieri Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement Arthritis Res. Ther. 6 2 2004 R137 R141
106. M.H. Wener, K. Hutchinson, C. Morishima, and D.R. Gretch Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia Arthritis Rheum. 50 7 2004 2305 2308
107. E. Berglin, L. Padyukov, U. Sundin, G. Hallmans, H. Stenlund, and W.J. van Venrooij A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis Arthritis Res. Ther. 6 2004 R303 R308
108. F.A. van Gaalen, S.P. Linn-Rasker, W.J. van Venrooij, B.A. de Jong, F.C. Breedveld, and C.L. Verweij Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study Arthritis Rheum. 50 3 2004 709 715
109. H. Visser, S. le Cessie, K. Vos, F.C. Breedveld, and J.M. Hazes How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis Arthritis Rheum. 46 2 2002 357 365
110. O. Meyer, C. Labarre, M. Dougados, P. Goupille, A. Cantagrel, and A. Dubois Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage Ann. Rheum. Dis. 62 2 2003 120 126
111. K. Forslind, M. Ahlmen, K. Eberhardt, I. Hafstrom, and B. Svensson Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP) Ann. Rheum. Dis. 63 9 2004 1090 1095
112. J. Ronnelid, J. Lysholm, A. Engstrom-Laurent, L. Klareskog, and B. Heyman Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid: evidence for an HLA-DR4-restricted IgG response Arthritis Rheum. 37 7 1994 123 129
113. J.S. Johansen, H.S. Jensen, and P.A. Price A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid Br. J. Rheumatol. 32 11 1993 949 955
114. M. Schaller, D.R. Burton, and H.J. Ditzel Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease Nat. Immunol. 2 8 2001 746 753
115. F. Jouen, O. Vittecoq, F. Leguillou, I. Tabti-Titon, J.F. Menard, and O. Mejjad Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis Clin. Exp. Immunol. 137 3 2004 606 611
116. I. Matsumoto, D.M. Lee, R. Goldbach-Mansky, T. Sumida, C.A. Hitchon, and P.H. Schur Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders Arthritis Rheum. 48 4 2003 944 954
117. F.A. van Gaalen, R.E. Toes, H.J. Ditzel, M. Schaller, F.C. Breedveld, and C.L. Verweij Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis Arthritis Rheum. 50 2 2004 395 399
118. D. Schubert, M. Schmidt, D. Zaiss, P.R. Jungblut, and T. Kamradt Autoantibodies to GPI and creatine kinase in RA Nat. Immunol. 3 5 2002 411 413
119. V. Saulot, O. Vittecoq, R. Charlionet, P. Fardellone, C. Lange, and L. Marvin Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis Arthritis Rheum. 46 5 2002 1196 1201
120. F. Pratesi, S. Moscato, A. Sabbatini, D. Chimenti, S. Bombardieri, and P. Migliorini Autoantibodies specific for alpha-enolase in systemic autoimmune disorders J. Rheumatol. 27 1 2000 109 115
121. W. Hassfeld, G. Steiner, K. Hartmuth, G. Kolarz, O. Scherak, and W. Graninger Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis Arthritis Rheum. 32 1989 1515 1520
122. W. Hassfeld, G. Steiner, W. Graninger, G. Witzmann, H. Schweitzer, and J.S. Smolen Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis Br. J. Rheumatol. 32 3 1993 199 203
123. S. Yamamoto, K. Shimizu, K. Shimizu, K. Suzuki, Y. Nakagawa, and T. Yamamuro Calcium-dependent cysteine proteinase (calpain) in human arthritic synovial joints Arthritis Rheum. 35 11 1992 1309 1317
124. N. Despres, G. Talbot, B. Plouffe, G. Boire, and H.A. Menard Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera J. Clin. Invest. 95 4 1995 1891 1896
125. K.J. Lackner, U. Schlosser, B. Lang, and G. Schmitz Autoantibodies against human calpastatin in rheumatoid arthritis: epitope mapping and analysis of patient sera Br. J. Rheumatol. 37 11 1998 1164 1171
126. F. Martin, and A.C. Chan Pathogenic roles of B cells in human autoimmunity: insights from the clinic Immunity 20 5 2004 517 527
127. M.J. Leandro, J.C. Edwards, and G. Cambridge Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion Ann. Rheum. Dis. 61 10 2002 883 888
128. G.C. Tsokos B cells, be gone - B-cell depletion in the treatment of rheumatoid arthritis N. Engl. J. Med. 350 25 2004 2546 2548
129. S.L. Bridges Jr. Genetic markers of treatment response in rheumatoid arthritis Arthritis Rheum. 50 2004 1019 1022
130. T.J. Oligino, and S.A. Dalrymple Targeting B cells for the treatment of rheumatoid arthritis Arthritis Res. Ther. 5 Suppl. 4 2003 S7 S11
131. N. Lonberg, and D. Huszar Human antibodies from transgenic mice Int. Rev. Immunol. 13 1 1995 65 93
132. R.H. Carter, and R.A. Barrington Signaling by the CD19/CD21 complex on B cells Curr. Dir. Autoimmun. 7 2004 4 32
133. A. Loffler, P. Kufer, R. Lutterbuse, F. Zettl, P.T. Daniel, and J.M. Schwenkenbecher A recombinant bispecific single-chain antibody, CD19 × CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes Blood 95 6 2000 2098 2103
134. A. Loffler, M. Gruen, C. Wuchter, F. Schriever, P. Kufer, and T. Dreier Efficient elimination of chronic lymphocytic leukaemia B cells by autologous T cells with a bispecific anti-CD19/anti-CD3 single-chain antibody construct Leukemia 17 5 2003 900 909
135. R.H. Carter B cell signalling as therapeutic target Ann. Rheum. Dis. 63 Suppl. 2 2004 ii65 ii66
136. A.B. Satterthwaite, and O.N. Witte The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective Immunol. Rev. 175 2000 120 127
137. F. Mackay, S.A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, and P. Schneider Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations J. Exp. Med. 190 11 1999 1697 1710
138. G.S. Cheema, V. Roschke, D.M. Hilbert, and W. Stohl Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases Arthritis Rheum. 44 6 2001 1313 1319
139. D.F. Legler, M. Loetscher, R.S. Roos, I. Clark-Lewis, M. Baggiolini, and B. Moser B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5 J. Exp. Med. 187 4 1998 655 660
140. K.M. Ansel, V.N. Ngo, P.L. Hyman, S.A. Luther, R. Forster, and J.D. Sedgwick A chemokine-driven positive feedback loop organizes lymphoid follicles Nature 406 6793 2000 309 314
141. S. Takemura, A. Braun, C. Crowson, P.J. Kurtin, R.H. Cofield, and W.M. O'Fallon Lymphoid neogenesis in rheumatoid synovitis J. Immunol. 167 2 2001 1072 1080
142. S. Ligier, P.R. Fortin, and M.M. Newkirk A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE Br. J. Rheumatol. 37 12 1998 1307 1314
143. M.M. Newkirk, R. Goldbach-Mansky, J. Lee, J. Hoxworth, A. McCoy, and C. Yarboro Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis Arthritis Res. Ther. 5 2 2003 R82 R90
144. S. Bas, S. Genevay, O. Meyer, and C. Gabay Anti-cyclic citrullinated peptide antibodies. IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis Rheumatology (Oxford) 42 5 2003 677 680
145. S. Dubucquoi, E. Solau-Gervais, D. Lefranc, L. Marguerie, J. Sibilia, and J. Goetz Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases Ann. Rheum. Dis. 63 4 2004 415 419
146. A. Saraux, J.M. Berthelot, V. Devauchelle, B. Bendaoud, G. Chales, and C. Le Henaff Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis J. Rheumatol. 30 12 2003 2535 2539
147. M. Simon, E. Girbal, M. Sebbag, V. Gomes-Daudrix, C. Vincent, and G. Salama The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies", autoantibodies specific for rheumatoid arthritis J. Clin. Invest. 92 3 1993 1387 1393
148. N. Despres, G. Boire, F.J. López-Longo, and H.A. Menard The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis J. Rheumatol. 21 6 1994 1027 1033
149. E.R. Vossenaar, A.J. Zendman, W.J. van Venrooij, and G.J. Pruijn PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease Bioessays 25 11 2003 1106 1118
150. A. Union, L. Meheus, R.L. Humbel, K. Conrad, G. Steiner, and H. Moereels Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay Arthritis Rheum. 46 5 2002 1185 1195
151. A.D. Cook, M.J. Rowley, I.R. Mackay, A. Gough, and P. Emery Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression Arthritis Rheum. 39 10 1996 1720 1727
152. G.F. Verheijden, A.W. Rijnders, E. Bos, C.J. Coenen-de Roo, C.J. van Staveren, and A.M. Miltenburg Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis Arthritis Rheum. 40 6 1997 1115 1125
153. A. Guerassimov, Y. Zhang, S. Banerjee, A. Cartman, J.Y. Leroux, and Rosenberg Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate Arthritis Rheum. 41 6 1998 1019 1025
154. A.S. Korganow, H. Ji, S. Mangialaio, V. Duchatelle, R. Pelanda, and T. Martin From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins Immunity 10 4 1999 451 461
155. F.A. van Gaalen, R.E. Toes, H.J. Ditzel, M. Schaller, F.C. Breedveld, and C.L. Verweij Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis Arthritis Rheum. 50 2 2004 395 399
156. G. Steiner, K. Hartmuth, K. Skriner, I. Maurer-Fogy, A. Sinski, and E. Thalmann Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex J. Clin. Invest. 90 3 1992 1061 1066
157. S. Blass, C. Specker, H.J. Lakomek, E.M. Schneider, and M. Schwochau Novel 68 kDa autoantigen detected by rheumatoid arthritis specific antibodies Ann. Rheum. Dis. 54 5 1995 355 360
158. M.S. Atta, K.L. Lim, D.A. Ala'deen, R.J. Powell, and I. Todd Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus Ann. Rheum. Dis. 54 2 1995 117 124
159. M. Shrivastav, B. Mittal, A. Aggarwal, and R. Misra Autoantibodies against cytoskeletal proteins in rheumatoid arthritis Clin. Rheumatol. 21 6 2002 505 510
160. S. Tanaka, K. Tatsumi, T. Tomita, M. Kimura, T. Takano, and H. Yoshikawa Novel autoantibodies to pituitary gland specific factor 1a in patients with rheumatoid arthritis Rheumatology (Oxford) 42 2 2003 353 356
161. H. Uesugi, S. Ozaki, J. Sobajima, F. Osakada, H. Shirakawa, and M. Yoshida Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases J. Rheumatol. 25 4 1998 703 709
162. A.H. Mulder, G. Horst, M.A. van Leeuwen, P.C. Limburg, and C.G. Kallenberg Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical correlations Arthritis Rheum. 36 8 1993 1054 1060
163. O. Vittecoq, F. Joen-Beades, K. Krzanowska, I. Bichon-Tauvel, J.F. Menard, and A. Daraagon Prospective evaluation of the frequency and clinical significance of antineutrophil cytoplasmic and anticardiolipin antibodies in community cases of patients with rheumatoid arthritis Rheumatology (Oxford) 39 5 2000 481 489
164. P.J. Delves, and I.M. Roitt Advances in immunology: the immune system New Engl J Med 343 1 2000 37 49 (first of two parts)